Northwest Biotehrpeutics: How Does DCVax-L Clinical Data Compare To The CAR-T Therapy Axi-Cel?

It is a paradox that people can look at the Kite phase 2 data on Axi-Cel and pronounce it as stunning as does Biotech Hawk and in the next breath dismiss phase 1/2 data on DCVax-L that appears much more encouraging.